Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000669465 | SCV000794221 | likely pathogenic | Bloom syndrome | 2017-09-20 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000669465 | SCV001590404 | pathogenic | Bloom syndrome | 2023-09-23 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Thr203Serfs*4) in the BLM gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in BLM are known to be pathogenic (PMID: 17407155). For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals affected with BLM-related conditions. This variant is not present in population databases (gnomAD no frequency). |
Revvity Omics, |
RCV000669465 | SCV002018429 | pathogenic | Bloom syndrome | 2019-02-12 | criteria provided, single submitter | clinical testing |